Delta-Fly Pharma, Inc. Financial Overview
Delta-Fly Pharma, Inc.'s market cap is currently ¥6.32B. The company's EPS TTM is ¥-41.61; its P/E ratio is -3.21; Delta-Fly Pharma, Inc. is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
